Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
OKYO Pharma Limited - Ordinary Shares
(NQ:
OKYO
)
2.110
+0.040 (+1.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
244,907
Open
2.100
Bid (Size)
2.050 (3)
Ask (Size)
2.150 (79)
Prev. Close
2.070
Today's Range
2.010 - 2.150
52wk Range
0.9016 - 3.349
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OKYO Pharma Announces Chairman and Founder Acquires Shares
October 16, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Stock Rises After Company Outlines Development Pathway For Neuropathic Corneal Pain Drug
September 22, 2025
Via
Stocktwits
Performance
YTD
+86.7%
+86.7%
1 Month
+0.5%
+0.5%
3 Month
-27.2%
-27.2%
6 Month
+73.0%
+73.0%
1 Year
+101.0%
+101.0%
More News
Read More
OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
September 22, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
July 17, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 16, 2025
Via
Benzinga
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
July 16, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 15, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 16, 2025
Via
Benzinga
Goldman Small Cap Research Issues New Research Update on OKYO Pharma Limited
June 11, 2025
Via
ACCESS Newswire
OKYO Pharma to Present at the Bio International Convention
June 11, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
May 19, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain
May 01, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
April 30, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
March 31, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
March 10, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
February 12, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Announces Chairman and CEO Acquire Shares
January 31, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited
January 30, 2025
Via
ACCESS Newswire
OKYO Pharma to Complete Enrollment of Neuropathic Corneal Pain Trial by End of Second Quarter
January 29, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
January 22, 2025
From
OKYO Pharma LTD
Via
GlobeNewswire
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference
November 26, 2024
From
OKYO Pharma LTD
Via
GlobeNewswire
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
November 15, 2024
Via
ACCESSWIRE
OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference
October 30, 2024
From
OKYO Pharma LTD
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
Via
Benzinga
Frequently Asked Questions
Is OKYO Pharma Limited - Ordinary Shares publicly traded?
Yes, OKYO Pharma Limited - Ordinary Shares is publicly traded.
What exchange does OKYO Pharma Limited - Ordinary Shares trade on?
OKYO Pharma Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for OKYO Pharma Limited - Ordinary Shares?
The ticker symbol for OKYO Pharma Limited - Ordinary Shares is OKYO on the Nasdaq Stock Market
What is the current price of OKYO Pharma Limited - Ordinary Shares?
The current price of OKYO Pharma Limited - Ordinary Shares is 2.110
When was OKYO Pharma Limited - Ordinary Shares last traded?
The last trade of OKYO Pharma Limited - Ordinary Shares was at 10/16/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.